Prostate Cancer

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC [Phase 2]

  A Phase II study assesses AAA617 alone and in combination with an androgen receptor pathway inhibitor (ARPI) for PSMA PET scan-positive cast…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors [NA]

  Clinical trial evaluating pencil beam scanning proton therapy for previously irradiated tumors, currently in recruiting status.

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer [Phase 1]

  A Phase 1 clinical trial evaluating JNJ-78278343, a T-cell–redirecting agent targeting KLK2, for advanced prostate cancer is currently liste…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations [Phase 2]

  This clinical trial update describes a Phase 2 study evaluating talazoparib in patients with advanced cancers and DNA repair variations, and…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy [Phase 3]

  Phase 3 study evaluating apalutamide in men with high-risk localized or locally advanced prostate cancer who are candidates for radical pros…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells [Phase 2]

  A Phase 2 clinical trial is evaluating the safety and effectiveness of Lutetium-177 dotatate for metastatic prostate cancer with neuroendocr…

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer [Phase 2]

  A Phase 2 clinical trial evaluating a fatty acid synthase inhibitor for castration-resistant prostate cancer is currently recruiting. The sp…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Micro-UltraSound In Cancer - Active Surveillance [NA]

  University of Alberta is recruiting for a trial evaluating Micro-UltraSound technology for active surveillance in prostate cancer.

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial [NA]

  The UPRISE trial is investigating a urine-based screening method combined with MRI for early detection of prostate cancer and is currently n…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer [Phase 1]

  This clinical trial update reports an active-not-recruiting Phase 1 study evaluating comparative formulations of Niraparib and Abiraterone A…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS [Phase 3]

  A Phase 3 clinical trial update for apalutamide (JNJ-56021927) in high-risk prostate cancer patients receiving primary radiation therapy (AT…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer [NA]

  This clinical trial update describes the water vapor ablation study for localized intermediate-risk prostate cancer and notes that the trial…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France

  A study assessing adherence to apalutamide in men with metastatic hormone-sensitive prostate cancer in France is currently recruiting.

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer [Phase 1]

  A Phase 1 clinical trial evaluating Pasritamig (JNJ-78278343) in combination with JNJ-86974680 for prostate cancer is currently recruiting.

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]

  Clinical trial update indicates Gedatolisib in combination with Darolutamide is being studied in metastatic castration-resistant prostate ca…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: High-Dose Brachytherapy in Treating Patients With Prostate Cancer [NA]

  An ongoing clinical trial evaluating high-dose brachytherapy for prostate cancer across multiple stages; the study is currently active but n…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer [NA]

  A clinical trial update for multimodal telerehabilitation in rural patients with advanced prostate cancer; the study is currently recruiting…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer [NA]

  Clinical trial update noting a study on posterior extra-fascial robot-assisted radical prostatectomy for intermediate- to high-risk prostate…

• CLINICAL_TRIALS trial_result · 2026-04-09
  Clinical Trial Update: Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer [Phase 2]

  A Phase 2 trial is evaluating Radium-223 dichloride in combination with hormone therapy and SBRT for metastatic prostate cancer. The study h…

• CLINICAL_TRIALS research · 2026-04-09
  Clinical Trial Update: 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer [Phase 3]

  A Phase 3 clinical trial evaluating 64Cu-SAR-bisPSMA PET imaging for biochemical recurrence of prostate cancer; the study is currently recru…

• CLINICAL_TRIALS research · 2026-04-09
  Clinical Trial Update: [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer [NA]

  This clinical trial involves PET imaging with [18F]-FDG and [18F] Dihydro-Testosterone to study progressive prostate cancer. The study is cu…

• CLINICAL_TRIALS research · 2026-04-09
  Clinical Trial Update: Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

  A Phase 1 study of ACE-232 for metastatic castration-resistant prostate cancer is currently recruiting.

• CLINICAL_TRIALS research · 2026-04-09
  Clinical Trial Update: The Effect of Mobile-Based Perioperative Education on Urinary Incontinence and Erectile Function After Radical Prostatectomy [NA]

  The clinical trial update indicates that a study evaluating mobile-based perioperative education to improve urinary incontinence and erectil…

• CLINICAL_TRIALS trial_result · 2026-04-09
  Clinical Trial Update: Cost-utility of Focal HIFU vs Prostatectomy [NA]

  An ongoing clinical trial sponsored by University Hospital, Bordeaux, evaluating the cost-utility of focal high-intensity focused ultrasound…

• CLINICAL_TRIALS research · 2026-04-09
  Clinical Trial Update: A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

  A real-world observational study in U.S. urology clinics to examine how darolutamide and other androgen receptor pathway inhibitors are used…